Piribo: Prescription Drugs for Women Could Reach $63bn Within Four Years

Piribo, (http://www.piribo.com) the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called “Women’s Health: Worldwide Prescription Drug Markets” (http://www.piribo.com/search/results.html?k=kal087&x=0&y=0) which predicts that the global market for pharmaceutical treatments for women’s health problems could reach $63 billion by 2010.

(PRWEB) August 18, 2006 -- Piribo, (http://www.piribo.com) the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report called “Women’s Health: Worldwide Prescription Drug Markets” (http://www.piribo.com/search/results.html?k=kal087&x=0&y=0) which predicts that the global market for pharmaceutical treatments for women’s health problems could reach $63 billion by 2010.

Unprecedented advancements in the area of women’s health and worldwide recognition of the importance of addressing conditions that overwhelmingly affect women, underscore this growth.

According to the report, 2005 revenues for therapeutics addressing women’s needs, such as autoimmune diseases, cancer, and menopause, among others, exceeded $45 billion. Indeed, from 2000 to 2005, the market grew by 10.5%.

One of the most important developments on the horizon of women’s health is the recent approval of a new cervical cancer vaccine, inaugurating a vaccine market potentially worth several billion dollars a year. The vaccine helps prevent infection from sexually transmitted strains of human papillomavirus (HPV), which causes the cancer. Similarly, the emergence of a possible vaccine-type treatment to prevent AIDS has shown great promise for women around the world.

While sales of hormone replacement drugs fell sharply from 2002 to 2004 on the heels of much publicized reports of the adverse health effects of long term HRT treatment, sales in most other segments have continued to show positive trends, according to the report.

Brief Table of Contents:
Chapter One: Executive Summary
Chapter Two: Introduction and Overview
Chapter Three: Autoimmune Diseases
Chapter Four: Cancer
Chapter Five: Gynecological Infections and Sexually Transmitted Diseases
Chapter Six: Hormone-Related Disorders
Chapter Seven: Osteoporosis
Chapter Eight: Urinary Bladder Disorders
Chapter Nine: Issues and Trends
Chapter Ten: World Market Summary
Chapter Eleven: Competitor Profiles

Women’s Health: Worldwide Prescription Drug Markets includes research and development pipelines; in-depth company profiles; four-region geographic breakdowns; and market size, growth, and share for the following product categories: autoimmune diseases; cancer; gynecological and STDs; hormones; osteoporosis; and urinary disorders. It is available from Piribo.

About Piribo.
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 3,800 English language titles including, market reports, studies and books and is the UK’s largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.

###

Press Contact: Fiona Brown
Company Name: PIRIBO LTD
Email: email protected from spam bots
Phone: 02070607474
Website: http://www.piribo.com/

¶ 11:10 AM